Utilising routine clinical laboratory data to support quality improvement in healthcare: Application of a national acute kidney injury alert system as a proof of concept.

Abstract

Acute kidney injury (AKI) is a global health issue known to cause avoidable harm and death. Improvement in its prevention and management is therefore considered an important goal for the healthcare sector. The work here aimed to develop a tool which could be used to robustly and reliably measure, monitor, and compare the effectiveness of healthcare interventions related to AKI across the Welsh NHS, a mechanism which did not exist previously. Using serum creatinine (SCr) as a biomarker for AKI and a validated national data set collected from the all Wales Laboratory Information Management System, work involved applying Donabedian's framework to develop indicators with which to measure outcomes related to AKI, and exploring the potential of statistical process control (SPC) techniques for analysing data on these indicators. Rate of AKI incidence and 30-day AKI associated mortality are proposed as valid, feasible indicators with which to measure the effectiveness of healthcare interventions related to AKI. The control chart, funnel plot, and Pareto chart are proposed as appropriate, robust SPC techniques to analyse and visualise variation in AKI-related outcomes. This work demonstrates that routinely collected large SCr data offers a significant opportunity to monitor and therefore inform improvement in patient outcomes related to AKI. Moreover, while this work concerns utilisation of SCr data for improvement in AKI strategies, it is a proof of concept which could be replicated for other routinely collected clinical laboratory data, to improve the prevention and/or management of the conditions to which they relate.